Biomarkers · Functional Fitness
Exercise Capacity (METs)
Higher values carry lower risk. Not measured in our NHANES panel; the curve is synthesised from the published association.
Hazard ratio relative to the curve's reference value, as synthesised from the published association.
Published hazard ratio1.73per unit (95% CI 1.35–2.22) · Mora S, Redberg RF, Cui Y, Whiteman MK, Flaws JA, Sharrett AR, Blumenthal RS. Ability of exercise testing to predict cardiovascular and all-cause death in asymptomatic women: a 20-year follow-up of the lipid research clinics prevalence study. JAMA. 2003;290(12):1600-1607.
Where people sit
Population percentiles (METs) by sex and age band. Cycle or source as recorded in the catalogue.
| Sex | Age | 5th | 25th | Median | 75th | 95th | n | Cycle / source |
|---|---|---|---|---|---|---|---|---|
| All | 20-39 | 2.66 | 4.89 | 6.44 | 7.99 | 10.2 | 2,994 | Peto et al. 2017 (Mort… |
| All | 40-59 | 3.22 | 5.45 | 7.00 | 8.55 | 10.8 | 2,994 | Peto et al. 2017 (Mort… |
| All | 60+ | 3.85 | 6.08 | 7.63 | 9.18 | 11.4 | 2,994 | Peto et al. 2017 (Mort… |
| All | all | 3.22 | 5.45 | 7.00 | 8.55 | 10.8 | 2,994 | Peto et al. 2017 (Mort… |
| Men | 20-39 | 2.79 | 5.02 | 6.57 | 8.12 | 10.4 | 2,994 | Peto et al. 2017 (Mort… |
| Men | 40-59 | 3.36 | 5.59 | 7.14 | 8.69 | 10.9 | 2,994 | Peto et al. 2017 (Mort… |
| Men | 60+ | 4.00 | 6.23 | 7.78 | 9.33 | 11.6 | 2,994 | Peto et al. 2017 (Mort… |
| Men | all | 3.36 | 5.59 | 7.14 | 8.69 | 10.9 | 2,994 | Peto et al. 2017 (Mort… |
| Women | 20-39 | 2.53 | 4.76 | 6.31 | 7.86 | 10.1 | 2,994 | Peto et al. 2017 (Mort… |
| Women | 40-59 | 3.08 | 5.31 | 6.86 | 8.41 | 10.6 | 2,994 | Peto et al. 2017 (Mort… |
| Women | 60+ | 3.69 | 5.93 | 7.48 | 9.03 | 11.3 | 2,994 | Peto et al. 2017 (Mort… |
| Women | all | 3.08 | 5.31 | 6.86 | 8.41 | 10.6 | 2,994 | Peto et al. 2017 (Mort… |
Sources
- Hazard curve: Peto et al. 2017 (PMID 28858850) anchor; external_cohort_anchor
- Mora S, Redberg RF, Cui Y, Whiteman MK, Flaws JA, Sharrett AR, Blumenthal RS. Ability of exercise testing to predict cardiovascular and all-cause death in asymptomatic women: a 20-year follow-up of the lipid research clinics prevalence study. JAMA. 2003;290(12):1600-1607.